As the population ages, the health issues of older citizens ill become increasingly important. The Einstein Aging study (EAS) focuses on the aging brain, examining both normal aging and the special challenges of Alzheimer's disease and other dementing disorders. The study has been supported by ...
BBC News features an article and video on the longevity research of Nir Barzilai, M.D., and his planned clinical study on the effects of the drug metformin on age-related disease. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein. (Thursday, December 21, 2017)
The Einstein Aging Study (EAS) is a longitudinal study of cognitive aging and dementia; the sample includes systematically recruited older adults drawn from an urban, multi-ethnic, community-dwelling population in Bronx County, NY. Participants receive comprehensive annual medical and neuropsychological evaluations.
project, the Einstein Aging Study. clinical evaluation During the study, subjects were interviewed with the use of a structured medical-history question-naire and were examined by study clinicians.
The Einstein Aging Study (EAS) is a longitudinal study of cognitive aging. Since 1980, the EAS team has examined both normal aging and challenges associated with aging, particularly Alzheimer’s disease and other dementias. EAS is a noteworthy study because it constitutes a large and racially and economically-diverse group of older adults.
The Einstein Aging Study, a community based study in the Bronx, provides an ideal setting for addressing the relationship between obesity, chronic pain and related comorbidities in the elderly. The study has long recruited a systematic sample of Bronx residents over the age of 70 using lists of registered voters.
TY - JOUR. T1 - Cerebral hemodynamics in the elderly a transcranial doppler study in the Einstein aging study cohort. AU - Yang, Dixon. AU - Cabral, Digna
Cross-sectional study. Setting. Community sample. Participants. Individuals aged 70 and older (mean 79.5, 54% female) without dementia participating in the Einstein Aging Study (N = 200). Measurements. All participants underwent TCD assessments and tests of lower extremity function at an annual clinic visit.
8/20/2008 · Roee Holtzer, Ph.D., and colleagues from the Albert Einstein College of Medicine, Yeshiva University, New York, evaluated 897 individuals, age 70 or older, who are part of The Einstein Aging Study, a longitudinal study of aging and dementia in Bronx County, New York.
5/4/2015 · As such, metformin is of particular interest in clinical translational research in aging since it may influence fundamental aging factors that underlie multiple age-related conditions. The investigators therefore propose a pilot study to examine the effect of metformin treatment on the biology of …
Address reprint requests to Dr. Verghese at the Einstein Aging Study, Albert Einstein College of Medicine, 1165 Morris Park Ave., Bronx, NY 10461, or at [email protected].
View Jacob Schrier’s profile on LinkedIn, the world's largest professional community. ... Einstein Aging Study. April 2018 – Present 1 year 1 month. Acquisitions and Asset Management Intern ...
Methods: As a sub-study in the Einstein Aging Study, 309 participants age≥70 initially free of dementia were administered the MBT and followed annually for incident dementia for up to 13 years ...
The 21-year study of senior citizens, 75 and older, was led by the Albert Einstein College of Medicine in New York City, funded by the National Institute on Aging, and published in the New England Journal of Medicine. Their method for objectively measuring mental acuity in aging was to monitor rates of dementia, including Alzheimer’s disease.
Individuals aged 70 and older (mean 79.5, 54% female) without dementia participating in the Einstein Aging Study (N = 200). Measurements. All participants underwent TCD assessments and tests of lower extremity function at an annual clinic visit. Average MBFV for anterior (left and right anterior and middle cerebral arteries (MCAs)) and ...
Objective: To assess whether the MBT predicts incident dementia better than a conventional list learning test in a longitudinal community-based study. Methods: As a sub-study in the Einstein Aging Study, 309 participants age ≥ 70 initially free of dementia were administered the MBT and followed annually for incident dementia for up to 13 years.
The Einstein Aging study (EAS) focuses on the aging brain, examining both normal aging and the special challenges of Alzheimer's disease and other dementing disorders.
TY - JOUR. T1 - Association between renal function and cognitive ability domains in the Einstein aging study. T2 - Journals of Gerontology - Series A Biological Sciences and Medical Sciences
Einstein Aging Study. Export as PDF. Cohort Acronym EAS Cohort type General population-based cohort Disease Alzheimer's disease, Frontotemporal dementia, Lewy body disease, Mild cognitive impairment (MCI), Parkinson's disease, Subjective memory complaints (SMC) or subjective cognitive decline (SCD), Vascular dementia
The Einstein Aging Study (EAS) has long focused on the risk factors and cognitive changes that predict the subsequent onset of dementia, particularly Alzheimer'...
Endpoints is an award-winning science publication by Elysium Health. Our goal is to encourage scientific literacy in biology and human health, and to improve the public perception of science. ... Einstein Aging Study: Inside a 40-Year Study on the Aging Brain.